Location: Convention Center: Mile High Ballroom 4EF
CE: Enduring CME: 0.25
Publication Number: 1320.3
Kenneth Kellner, Comer Children's Hospital at University of Chicago Medical Center, Elmhurst, IL, United States; Anne I. Sperling, University of Virginia, Charlottesville, VA, United States; Laura K. Johnston, University of Chicago Division of the Biological Sciences, Chicago, IL, United States; Christina E. Ciaccio, The University of Chicago, Chicago, IL, United States
Presenting Author(s)
Kenneth Kellner, MD
Fellow Comer Children's Hospital at University of Chicago Medical Center Elmhurst, Illinois, United States
Participants should be aware of the following financial/non-financial relationships:
Kenneth Kellner, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Anne I. Sperling, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Laura K. Johnston, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Christina E. Ciaccio, MD MSc: ● Aimmune (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator, Advisory Committee, Speaker Honorarium including speakers bureau, symposia, and expert witness). ● ALK (Ended In the Past 24 Months) (Products/Services: Advisory Committee). ● Clostrabio (Currently Ongoing) (Products/Services: Board Member or Executive Role, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds). ● DBV (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator). ● Genentech (Ended In the Past 24 Months) (Products/Services: Advisory Committee). ● Novartis (Currently Ongoing) (Products/Services: Contractor including contracted research, Advisory Committee). ● Siolta (Currently Ongoing) (Products/Services: Board Member or Executive Role, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).
